Valeant Pharma adds hedge fund executive, 2 others to board

Embattled drug company Valeant Pharmaceuticals has added three directors to its board, including an executive from activist investor Bill Ackman's hedge fund Pershing Square Capital Management.

See Full Article

Its shares climbed nearly 4 per cent in premarket trading shortly ahead of the Wednesday market open.

The Canadian drugmaker said Wednesday that Pershing Vice Chairman Stephen Fraidin has joined the board, along with pharmaceutical executive Dr. Fred Eshelman and former University of North Carolina president Thomas W. Ross. Dr. Anders Lonner also is leaving, so these moves will bump the board's size to 14 members, 12 of whom are independent.

Pershing Square holds a 6.3 per cent stake in Valeant, as one of its biggest shareholders, according to FactSet.

Fraidin is an attorney specializing in mergers and acquisitions. Eshelman is the founder and former CEO of Pharmaceutical Product Development Inc. and has worked in the pharmaceutical industry for 35 years, Valeant said.

Valeant Pharmaceuticals International Inc. is facing a Securities and Exchange Commission investigation and, separately, scrutiny from Congress over its drug pricing. CEO Michael Pearson also recently returned to work after missing two months due to some health problems.

Valeant will discuss its preliminary fourth-quarter results and update its forecast for 2016 on March 15. The company had said last month it was delaying that announcement due to Pearson's return to work.

The company also has said it would delay filing its 2015 annual report with regulators while it sorts out its former relationship with the mail-order pharmacy Philidor, which has raised questions about the accuracy of Valeant's financial reporting.

U.S.-traded shares of Valeant jumped nearly 4 per cent, or $2.49, to $65.64 shortly before markets opening Wednesday. That's about a quarter of the all-time high of $263.81 that the stock reached in August, shortly before the company's practice of buying rights to old drugs and jacking up the prices came under congressional scrutiny.



Advertisements

Latest Economic News

  • Lessons the tooth fairy can't teach: Allowances can help kids learn financial savvy

    Economic CBC News
    Robin Taub paid her two kids a weekly sum when they were younger in an effort to help teach them basic money skills. Now, they're living away from home at university, managing a budget, and friends tease them for being money-smart kids, she says — a riff on the title of her book, A Parent's Guide to Raising Money-Smart Kids. Source
  • More than 2M knives recalled after reports of blades breaking, injuries

    Economic CTV News
    The kitchenware company Calphalon Contemporary Cutlery is recalling more than two million knives and knife sets in Canada and the United States after reports of blades breaking during normal use or when they are dropped, posing a risk of lacerations. Source
  • Conference Board sees modest economic growth in 2017

    Economic CBC News
    The national economy should seen see a slight pick-up this year, the Conference Board of Canada said in a new report out Thursday. The independent research group said it sees overall growth of 1.9 per cent this year, up from the 1.3 per cent it expects will be reported for last year. Source
  • Delta Airlines wins right to appeal ruling in complaint involving obese passengers

    Economic CBC News
    The Supreme Court of Canada has allowed Delta Airlines to appeal a ruling involving a complaint by a Nova Scotia man alleging the airline discriminates against obese passengers. The court granted the company's appeal request Thursday. Source
  • SCC to hear appeal involving policy that advocate says discriminates against obese

    Economic CTV News
    OTTAWA -- The Supreme Court of Canada has granted Delta Air Lines leave to appeal a ruling that found a Halifax passenger rights advocate should be able to stand up for obese people even though he isn't overweight himself. Source
  • Trump taps CEOs of 5 job-offshoring firms for input on how to create jobs in America

    Economic CBC News
    President Donald Trump, who has vowed to stop U.S. manufacturing from disappearing overseas, will seek job-creation advice on Thursday from at least five companies that are laying off thousands of workers as they shift production abroad. Source
  • Trump taps CEOs of 5 job-offshoring firms for input on how to create jobs

    Economic CBC News
    President Donald Trump, who has vowed to stop U.S. manufacturing from disappearing overseas, will seek job-creation advice on Thursday from at least five companies that are laying off thousands of workers as they shift production abroad. Source
  • Loblaw fourth-quarter profit up 57% to $201M

    Economic CBC News
    ?Loblaw had $11.13 billion of revenue and a $201 million net profit in the fourth quarter, according to earnings announced Thursday morning. The profit amounted to 50 cents per share. The net profit was up 57 per cent or $73 million from a year earlier, while revenue was up $265 million or 2.4 per cent. Source
  • Loblaw Q4 profit up 57 per cent to $201M

    Economic CTV News
    BRAMPTON, Ont. -- Loblaw had $11.13 billion of revenue and a $201 million net profit in the fourth quarter. The profit amounted to 50 cents per share. The net profit was up 57 per cent or $73 million from a year earlier, while revenue was up $265 million or 2.4 per cent. Source
  • CIBC grows first-quarter net income to $1.41B

    Economic CBC News
    ?CIBC increased its first-quarter net income to $1.41 billion, up from $982 million a year ago, according to earnings announced Thursday morning. The quarterly earnings amounted to $3.50 per diluted share, compared with $2.43 per diluted share during the same period last year. Source